• Customer Login
  • Search
KindredBio
  • About
    • Background
    • Our Story
    • KindredBio Leadership
    • Board of Directors
  • Pipeline
    • Canine Pipeline
    • Clinical Trials
  • Products
    • Zimeta™ (dipyrone injection)
  • Technology
    • Veterinary Recombinant Biologics
    • Manufacturing Process
  • Education
    • Continuing Education
    • KINections
  • Investors
    • Investor Overview
    • Press Releases
    • Events & Presentations
    • Corporate Governance
    • Stock Information
    • Financial Information
    • Investor Resources
  • News
    • Press Releases
  • Contact Us
    • Contact Us
    • Careers
  • Menu

Archive for: CSS

You are here: Home / CSS

Single Portfolio: 2/3 Slider

Single Portfolio: 2/3 Gallery

Single Portfolio: Big Slider

KindredBio News

  • Kindred Biosciences to Announce First Quarter 2021 Financial Results
  • Kindred Biosciences Announces Acceptance of Parvovirus Antibody Prophylaxis Study Data and Approval of Efficacy Indication
  • Kindred Biosciences Unveils Positive Results from its Long-Acting Interleukin-31 Antibody PK Study
  • Kindred Biosciences Announces Fourth Quarter and Full Year 2020 Financial Results
  • Event: Kindred Biosciences to Announce Fourth Quarter and Full Year 2020 Financial Results

News Archives

  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • November 2016
  • October 2016
  • September 2016
  • August 2016
  • July 2016
  • June 2016
  • May 2016
  • April 2016
  • March 2016
  • February 2016
  • January 2016
  • December 2015
  • November 2015
  • August 2015
  • May 2015
  • March 2015
  • December 2014
  • November 2014
  • August 2014
  • June 2014
  • May 2014
  • April 2014
  • March 2014
  • February 2014
  • December 2013
  • August 2013
  • July 2013
  • March 2013
  • February 2013
  • January 2013

News

  • Kindred Biosciences to Announce First Quarter 2021 Financial ResultsMay 3, 2021 - 9:04 am
  • Kindred Biosciences Announces Acceptance of Parvovirus Antibody Prophylaxis Study Data and Approval of Efficacy IndicationApril 28, 2021 - 8:40 am
  • Kindred Biosciences Unveils Positive Results from its Long-Acting Interleukin-31 Antibody PK StudyApril 20, 2021 - 4:05 pm

Events

  • Event: Kindred Biosciences to Announce Fourth Quarter and Full Year 2020 Financial ResultsMarch 8, 2021 - 8:48 am
  • Event: Kindred Biosciences to Present at the H.C. Wainwright Global Life Sciences ConferenceMarch 2, 2021 - 8:45 am
  • Event: Kindred Biosciences to Present at the Barclays Global Healthcare ConferenceMarch 2, 2021 - 8:43 am
$4.63 Stock is Up 0.01 (0.22%)
KIN (Common Stock)
Previous Close Volume
$4.62 292,202
Intraday High Intraday Low
$4.66 $4.55
52 Week High 52 Week Low
$6.00 $3.20
Exchange: NASDAQ CM
Contact Us | Careers | Privacy Policy | Website Terms of Use | Forward Looking Statements
© Copyright 2012-2020 | Kindred Biosciences, Inc. | 1555 Bayshore Hwy. Suite 200 Burlingame, CA 94010
Scroll to top